Clinical Cancer Research Molecular Diagnostics in Cancer Therapeutic Development: Fulfilling the Promise of Personalized Medicine Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, B. L.
Right arrow Articles by Nam, S. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, B. L.
Right arrow Articles by Nam, S. Y.
Clinical Cancer Research Vol. 11, 2518-2525, April 2005
© 2005 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Nuclear Factor-{kappa}B Activation Correlates with Better Prognosis and Akt Activation in Human Gastric Cancer

Byung Lan Lee1, Hye Seung Lee2, Jieun Jung1, Sung Jin Cho1, Hee-Yong Chung3, Woo Ho Kim4, Young-Woo Jin5, Chong Soon Kim5 and Seon Young Nam1,5

Authors' Affiliations: Department of 1 Anatomy, Seoul National University College of Medicine, Seoul, Korea; 2 Department of Pathology, Seoul National University Bundang Hospital, Gyeonggi, Korea; 3 Department of Microbiology, Hanyang University College of Medicine; 4 Department of Pathology, Seoul National University College of Medicine; and 5 Division of Radiation Effect Research, Radiation Health Research Institute, Korea Hydro & Nuclear Power Co., Seoul, Korea

Requests for reprints: Seon Young Nam, Division of Radiation Effect Research, Radiation Health Research Institute, Korea Hydro & Nuclear Power Co., Seoul 132-703, Korea. Phone: 82-2-3499-6691; Fax: 82-2-3499-6660; E-mail: seonynam{at}khnp.co.kr.

Purpose: Because the biological significance of constitutive nuclear factor-{kappa}B (NF-{kappa}B) activation in human gastric cancer is unclear, we undertook this study to clarify the regulatory mechanism of NF-{kappa}B activation and its clinical significance.

Experimental Design: Immunohistochemistry for NF-{kappa}B/RelA was done on 290 human gastric carcinoma specimens placed on tissue array slides. The correlations between NF-{kappa}B activation and clinicopathologic features, prognosis, Akt activation, tumor suppressor gene expression, or Bcl-2 expression were analyzed. We also did luciferase reporter assay, Western blot analysis, and reverse transcription-PCR using the SNU-216 human gastric cancer cell line transduced with retroviral vectors containing constitutively active Akt or the NF-{kappa}B repressor mutant of I{kappa}B{alpha}.

Results: Nuclear expression of RelA was found in 18% of the gastric carcinomas and was higher in early-stage pathologic tumor-node-metastasis (P = 0.019). A negative correlation was observed between NF-{kappa}B activation and lymphatic invasion (P = 0.034) and a positive correlation between NF-{kappa}B activation and overall survival rate of gastric cancer patients (P = 0.0228). In addition, NF-{kappa}B activation was positively correlated with pAkt (P = 0.047), p16 (P = 0.004), adenomatous polyposis coli (P < 0.001), Smad4 (P = 0.002), and kangai 1 (P < 0.001) expression. An in vitro study showed that NF-{kappa}B activity in gastric cancer cells is controlled by and controls Akt.

Conclusions: NF-{kappa}B activation was frequently observed in early-stage gastric carcinoma and was significantly correlated with better prognosis and Akt activation. These findings suggest that NF-{kappa}B activation is a valuable prognostic variable in gastric carcinoma.

Key Words: NF-{kappa}B • prognosis • gastric cancer • Akt




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
G. Sethi, B. Sung, and B. B. Aggarwal
Nuclear Factor-{kappa}B Activation: From Bench to Bedside
Experimental Biology and Medicine, January 1, 2008; 233(1): 21 - 31.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. Zhang, X. Jin, F. Wang, S. Wang, C. Deng, Z. Gao, and C. Guo
Combined Prognostic Value of Both RelA and I{kappa}B-{alpha} Expression in Human Non Small Cell Lung Cancer
Ann. Surg. Oncol., December 1, 2007; 14(12): 3581 - 3592.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.